13Apr 2021

USE OF CHLOROQUINE IN ASYMPTOMATIC ELDERLY COVID19 PATIENTS, A PLACEBO OR RATHER A SOURCE OF COMPLICATIONS: A CASE REPORT

  • Cardiologist and PhD at Ibn Zohr University, Agadir, Morocco, Provincial Hospital Ibnou Baja, Taza, Morocco.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • Cite This Article as
  • Corresponding Author

Coronavirus 19 is a virus that caused a pandemic that started in Wuhan, CHINA in December 2019. Whatever it is a respiratory tropism virus, it can cause thromboembolic complications. The disease seems to be more severe in older patients with this virus. However, the introduction of treatment for this purpose remains to be discussed in asymptomatic older subjects. We report the case of a 90-year-old man positive for covid 19 but totally asymptomatic on admission. The administration of chloroquine combined with azithromycin caused digestive side effects leading to dehydration, probably resulting in cerebral venous thrombosis on the 5th day of treatment. The review of the literature and in the absence of large cohort studies demonstrating the value of these treatments, leads us to propose treatment on a case-by-case basis and even better to avoid it in asymptomatic elderly subjects without comorbidities.


[Benyamna I (2021); USE OF CHLOROQUINE IN ASYMPTOMATIC ELDERLY COVID19 PATIENTS, A PLACEBO OR RATHER A SOURCE OF COMPLICATIONS: A CASE REPORT Int. J. of Adv. Res. 9 (Apr). 197-204] (ISSN 2320-5407). www.journalijar.com


Benyamna Ilham
Ibn Zohr University , Agadir
Morocco

DOI:


Article DOI: 10.21474/IJAR01/12673      
DOI URL: http://dx.doi.org/10.21474/IJAR01/12673